ACE2 and early-onset autosomal dominant Alzheimer disease: Consistent with previously reported Western blotting and RT–PCR results obtained by our laboratory as well as others [53,54,55,56], ACE2 expression levels were higher in the brains of Alzheimer’s disease patients compared to controls as monitored by immunohistochemistry (Panel (c)).